| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |